Gralise 300 & 600 300 mg, 600 mg Prolonged-release tablet
PDF Leaflet Revision Date: 12 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of post-herpetic neuralgia in adults.
Dosage (summary)
Titrate to 1800 mg once daily with evening meal.
Special Populations
- Elderly patients
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy; caution in breastfeeding.
Key Drug Interactions
- CNS depressants
- Morphine
- Antacids
Contraindications
- Hypersensitivity to gabapentin
- Severe renal impairment
Common side effects
- Dizziness
- Somnolence
- Fatigue
Counselling Points
- Take with food
- Do not crush tablets
- Monitor for signs of suicidal thoughts
Serious warnings
- Risk of DRESS
- Anaphylaxis
- Suicidal ideation
Important Disclaimer
The Gralise 300 & 600 300 mg, 600 mg Prolonged-release tablet professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
